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Malaria caused by Plasmodium falciparum remains a public health problem in Nigerian children with 
treatment complicated by expansion of chloroquine resistant strains known to harbour a common K76T 
point mutation in their pfcrt alleles. Here, we report the outcome of a 2 – year (March 2000 – February 
2002) molecular surveillance for pfcrtT76 in children aged 6 months – 13 years with acute 
uncomplicated falciparum malaria in rural and urban Lagos, Nigeria.  Rural-urban pfcrtT76 acquisition 
of 48.7 vs. 73.7% and 67.3 vs. 74.6% due to monoclonal and polyclonal P. falciparum parasitaemia, 
respectively, were found in the two study years, suggesting unstable but increasing prevalence of pfcrt 
T76 allele acquisition in the rural area. Further analyses showed that acquisition of pfcrtT76 allele was 
independent of sex but occurred more in  5 – year old children than older children in both populations. 
The impacts of K76T mutation in pfcrt gene and immunity on the clinical efficacy of chloroquine against 
acute uncomplicated malaria are discussed.  
 





In Nigeria, malaria caused by Plasmodium falciparum 
remains a public health problem as it accounts for 25% 
of infant mortality, 30% of childhood mortality and 
represents a major hyperpyrexia factor in children and 
adults (Mosanya, 1997; Salako et al., 2001; Elesa et al., 
1993). The magnitude of failure to control malaria 
chemotherapeutically with chloroquine has increased 
significantly in the past 5 years owing to increased trend 
of the incidence of RI, RII and RIII parasitological 
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(Lege-Oguntoye et al., 1989; Anitia Obong et al., 1997; 
Ezedinachi et al., 1999). This clinical scenario has been 
blamed on the expansion and intensification of 
chloroquine resistance P. falciparum clones first reported 
from the Eastern part of the country in 1986 (CDC, 
1987). Promotive factors include adulteration, self-
medication and pre-treatment sub-therapeutic levels of 
chloroquine especially in children (Mockenhaupt et al., 
2000). Genetic studies by Adagu and Warhurst (2001) 
have identified lysine (K) to threonine (T) point mutation 
in codon 76 of pfcrt gene, which encodes a putative 
chloroquine anion transporter protein PFCRT in strains 
that displayed reduced susceptibility to chloroquine in 
vitro. A recent study by Happi et al. (2004) identified pfcrt  
. 
 





T76 as a genetic marker of recrudescence in children 
with acute uncomplicated falciparum malaria. 
Meanwhile, the recently reported epidemiological wave 
of chloroquine resistance malaria with clinical outcome 
improved with chloroquine-chlorapheniramine in Lagos 
(Okonkwo et al., 1999) lacks genetic evidence regarding 
the impact of pfcrt K76   T mutation in terms of spread 
and pattern of acquisition in both rural and urban areas 
where malaria is endemic and transmission is perennial.  
In the present study, we have reported the trend of 
acquisition of pfcrtT76 allele in the last two years from 
the pre-treatment samples of children presenting acute 
uncomplicated Plasmodium falciparum at a Primary 
Health facility in Ijede, a rural settlement and Massey 
Street Children’s Hospital in Lagos metropolis. The 
effects of age and sex on the acquisition of this allele 
were also investigated. 
 
 




One hundred and ninety six (196) children aged 6 months to 13 
years presenting with acute uncomplicated P. falciparum malaria 
were enrolled in the study. The cohorts were recruited from a 
Primary Health Care Centre in Ijede (N = 91; M/F = 48/43), a rural 
settlement, located about 40 km from Lagos Mainland and Massey 
Street Children Hospital (N = 105; M/F = 54/51), located in a 
crowded part of Urban Lagos and provides secondary health 
service for an average of 300 to 400 sick children per day. In both 
sites, falciparum malaria is endemic with perennial transmission. 
The main transmitting vectors are Anopheles gambie complex and 
A. funestus (Afolabi et al., 2001 Salako et al., 1990). The children 
were enrolled based on fever presentation or appearance of fever 
(body temperature  37.5°C) in the last 24 to 48 h, microscopic 
detection of absolute P. falciparum parasitaemia of  2000 asexual 
forms/ml of whole blood and absence of concomitant illness. 
A written informed consent for each sick child was obtained from 
a parent or guardian as a criterion for enrollment into the study. 
The study was approved by the Hospital Management Board, 
Lagos. Nigeria and spanned from March, 2000 to February 2002.  
 
 
Thin and thick blood film microscopy 
 
Each sick child was finger-pricked using a sterile lancet and drops 
of whole blood collected on labeled grease-free slide were used to 
make thick and thin blood films for quantitation of parasitaemia and 
speciation.  
The parasite density was determined by counting the number of 
asexual forms of P. falciparum microscopically (X1000 
magnification) on 5% Giemsa-stained thick film slide against 200 – 
500 leukocytes with the assumption that there are 8000 leukocytes 
per l of blood.  
Two drops of blood from each patient were also blotted onto 3 
MM Whatman filter paper air-dried, stored in air-tight container and 
subsequently used for extraction of P. falciparum DNA and 






Amplification of the pfcrt locus  
 
Parasite genomic DNA was extracted from the blood-spotted and 
dried filter paper by methanol fixation and heat extraction according 
to Snounou et al. (1993). 5-10 l aliquot of the extracted DNA was 
further amplified in vitro by nested PCR in a primary reaction 
reaction volume of 20 l to generate a primary fragment (outer pfcrt 
locus = 260 bp) that was subsequently used as a template (1.0 l) 
for the secondary PCR to generate a secondary fragment (inner 
pfcrt locus = 134bp) (Djimde et al., 2001). Two sets of primer pair 
based on sequence homology to pfcrt gene (GenBank accession 
AF030694) from Roche Diagnostics, GmBH, Germany were used. 
They were CRTI (CCGTTAATAATAAATACACGCAG) and CRT2 
(CGGATGTTACAAAACTATAGTTACC) for primary PCR of 45 
cycles (95oC, 30 s; 56oC, 30 s; 60oC, 60 s) and a final extension of 
60oC, 5 min followed by the use of CRTD1 
(TGTGCTCATGTGTTTAAACTT) and CRTD2 
(CAAAACTATAGTTACCAATTTTG) for secondary PCR of 30 
cycles (95oC, 30 s; 56oC, 30 s; 60oC, 30 s) and a final extension of 
65oC for 5 min. Each PCR began with a 3-min pre-PCR step at 
95oC.  
The resulting PCR products (10 l) were electrophoresed on a 
2% agarose gel, stained with ethidium bromide (5 g/ml) and have 
their molecular weight determined by extrapolation using a 100-bp 
ladder of molecular weight markers (Invitogen Life Technologies, 
Netherlands) under ultraviolet violet transillumination. 
 
 
Restriction endonuclease digestion of pfcrt  
 
5 l of secondary fragment representing the inner pfcrt locus (size 
= 134 bp) within which K76T point mutation exists was digested 
overnight with 0.5 U AcsI at 370C. Digestion to 34 and 100 bp 
fragments indicates wild type pfcrt allele with lysine (K) encoded by 
codon 76 of the gene, while the mutant pfcrt allele with threonine 
(T) at position 76 is uncut by the restriction enzyme (Djimde et al., 
2001). Pfcrt alleles from P. falciparum DD2 and HB3 strains were 
used as wild and mutant controls, respectively. Allelic frequency 
rate (R) was defined as the proportion of pfcrt T76 in year 2 to that 





Data were presented as proportions and stratified by age and sex. 
Disparity between proportions was evaluated using the STATCALC 





The data in Table 1 summarized the outcome of a 2- 
year molecular surveillance study of the acquisition of 
pfcrt T76, a chloroquine resistant gene marker by 
children with acute uncomplicated P. falciparum malaria 
in the two study populations. 19 of 39 (Ijede) and 31 of 
42 (Massey Street Children’s Hospital) pre-treatment 
blood samples were found to harbour the pfcrt T76 
mutant allele of P. falciparum in the year 2000 – 2001, 
corresponding to frequencies of 48.7% and 73.8%, 
respectively (χ2 Mantel-Haenszel= 4.4; P = 0.04).  In the 
year 2001 – 2002, the allelic frequencies of the mutant 
allele were 67.3% and 74.6%, respectively (χ2 Mantel- 
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Table 1. Parasitaemia profile and incidence of pfcrt T76 allele acquisition in children with acute uncomplicated 
Plasmodium falciparum malaria in rural and urban Lagos, Nigeria. 
 
Study site 
Ijede (Rural)       R Massey Hospital (Urban) 
Period N n(%)pfcrtT76 (+ve)@ N n(%)pfcrtT76 (+)@ χ2 P 
Year 1 39 19(48.7) 42 31(73.8) 4.4 0.04 
Year 2 52 33 (67.3)* 63 47 (74.6) 1.7 0.2 
Total 91 52 (57.1) 105 78 (74.3) 6.4 0.1 
 
N = Pre-treatment sample size. Parasitaemia = 2080 – 24,420 asexual forms /l of blood; Geometric mean = 2138 /l. @, 
Data represent number and percentage (in parenthesis) of cases positive by PCR-RFLP for pfcrt T76 in both monoclonal 
(pfcrt T76 band only) and polyclonal (pfcrtK76/T76 bands seen) parasitaemia. Differences in proportions between and within 
groups on yearly basis were analyzed by chi-square test with Mantel -Haenszel modification. * P < 0.05 versus year 1 rural. 




Table 2. Gender variation in the acquisition of pfcrtT76 
allele in rural and urban Lagos, Nigeria. 
 
Rural Sex 
Period  M F χ2 P 
Year 1 11(57.9) 8(42.1) 0.92 0.3 
Year 2 18(54.5) 15(45.5) 0.54 0.5 
Total 29(55.8) 23(44.2) 1.37 0.2 
Urban  
Year 1 18(58.1) 13(41.9) 1.59 0.2 
Year 2 26(55.3) 15(44.7) 0.54 0.5 
Total 44(56.4) 34(43.6) 1.37 0.2 
 
Figures in parenthesis represent percentages of pfcrt T76 positive 
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Figure 1. Age distribution of pfcrt T76 allele due to monoclonal 
(single infections) and polyclonal (mixed infections) Plasmodium 





Haenszel= 1.7; P = 0.2). Allelic frequency rates in Ijede 
(rural) and Massey Hospital (urban) were 1.38/year and 
1.01/year, respectively. 
Further stratification of the acquired pfcrt T76 allele by 
age revealed no significant difference (P > 0.05) in both 
populations (Table 2). However, children of age < 5 
years were found to acquire the allelic mutant more than 
older children in both populations (59.0% vs. 41.0%; 
rural = 61.5% vs. 38.5%; P < 0.05) Table 3.  The 
parasitaemia characteristics of the pre-treatment blood 
samples revealed acquisition of the mutant allele in 
monoclonal infections (pfcrt T76 only) and polyclonal 
infections (i.e. mixed infection due to wild, pfcrt K76 and 
mutant allele parasitaemia) (Figure 1). The alleles were 
identified by PCR-RFLP of primary fragments as 100 bp 
(wild allele) and 134 bp (mutant allele) molecular size 





The present study has revealed increasing and high 
prevalence of pfcrt T76 P. falciparum strains in rural and 
urban Lagos which is similar to observations in other 
parts of the country where chloroquine resistant strains 
have long emerged and now exhibiting expansion and 
intensification (Abdulahi et al., 2003; Happi et al., 2004). 
To our knowledge, this is the first report of pfcrtK76T 
mutant P. falciparum strains in the study area.   
The pfcrt gene, which regulates intracellular parasite 
physiology and found crucial to parasite viability in 
infected erythrocyte (Waller et al., 2001) evolves from the 
K76 wild type to T76 mutant allele most likely as a result 
of parasite exposure to sub-therapeutic doses of 
chloroquine (Fidock et al, 2000).  The national health 
policy that allows presumptive treatment of fever in 
children with chloroquine by care givers (i.e mothers, 
guardians etc) at home often provides wide ground for 
chloroquine abuse and under dosing (Ezedinachi et al,  
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Table 3. Comparison of pfcrt T76 allele acquisition in less than 5-year old and older children for 2 years in rural and 
urban Lagos, Nigeria.  
 
Age group       Ijede (Rural)     Massey Hospital (Urban) 
< 5 years 32 (61.5) 46 (60.0) 
> 5 years 20 (38.5) 32 (40.0) 
Total 52 (100.0) 78 (100.0) 
 2 = 5.5; P = 0.02 2 = 5.0; P=0.03 
 
Figures represent number and percentages of pfcrt T76 positive cases in the two age groups. Disparity between 































Figure 2. PCR-RFLP of secondary pfcrt amplicon (134 bp) of P. falciparum strains recovered from the pretreatment 
blood samples of children with acute uncomplicated malaria.  Lanes 1 and 15 = 100 bp ladder DNA markers. Lanes 2 – 
11: Pretreatment P. falciparum infected blood samples. Lane 12:  DD2 P. falciparum (wild pfcrt K76 control). Lane 13: 




 1997). This is because withdrawal of chloroquine 
especially in rural areas where microscopists are lacking 
and diagnosis is presumptive is often based on the 
clearance  of  clinical  symptoms  and  not   parasitaemia 
(Ramson-Kuti, 1989; Ezedinachi et al, 1997). 
The significantly high incidence of pfcrt T76 allele 
among < 5 years old children in the study population 
agrees with the finding of May and Meyer (2003) who 
observed an inverse correlation between pfcrt T76 
acquisition and age of 100 Nigerian children with 
asymptomatic falciparum malaria in Abanla, a village with 
health post facility in Ibadan. The age pattern of 
acquisition of pfcrt T76 observed in this study may 
therefore be a reflection of chloroquine abuse and also 
represent a strong predisposing factor to altered 
chloroquine clinical efficacy observed in this age group in 
the country (Mockenhaupt et al., 2000; Happi et al., 
2004). 
The observed 48.7 – 64.5% frequencies of pfrt T76 in 
rural Lagos is similar to the observations in the Sudan 
where pfcrtT76 allelic frequency has been found to 
increase at a rate of 0.217 per year (Abdel-Muhsin et al., 
2004). In urban Lagos, the allelic frequency of 73.4 – 
74.7 is comparable to 79% found in the pretreatment 
samples of malaria patients residing in a holoendemic 
region in Senegal (Thomas et al., 2002) and 82% found 
among malaria patients in Burkina Faso (Tinto et al., 
2003), and is higher than 40 – 61.5% observed in 
traveler malaria cases (Labbe et al., 2003) but lower than 
94% reported from an endemic area in Bangladesh (Van 
den Broek et al., 2004). Happi et al. (2003) had 
previously reported pfcrt T76 allelic frequencies of 48% 
in pretreatment samples of children with acute 
uncomplicated malaria living in other parts of the country 
with similar malaria endemicity and transmission. 
The clino-pathogenic consequences of pfcrt T76 
selection by endemic P. falciparum strains in a malarious 
area are manifold. From pathogenic perspectives, 
studies have shown that pfcrt T76 acquisition favours 
severity and multiplicity of malaria infection (Ranjit et al., 
2004).  This agrees with previous reports that malaria 
complications such as anaemia (Hb < 5g /dl), and 
cerebral malaria are the major causes of death in 







other African countries where pfcrt T76 P. falciparum 
clones are also a public health menace (Angyo et al, 
1996; Olumese et al, 2002). 
In clinical context, data concerning the 
pharmacological disposition of mutant P. falciparum 
strains to chloroquine and other heme binding 
antimalarials are grossly inconsistent. Whereas many in 
vitro work ranging from allelic exchange to 
complementation studies have effectively demonstrated 
the association of pfcrt T76 with chloroquine resistance 
and hence drug failure (Fidock et al., 2000). In vivo 
studies have contrary findings. For instance, in the work 
of Happi et al. (2003), pfcrt T76 alleles were found at 
comparable frequencies in the pretreatment samples of 
children that failed chloroquine and those with successful 
chloroquine treatment and in Garbon the allele was also 
observed in patients whose parasitaemia were cleared 
by chloroquine without recrudescence (Ranford et al., 
1997). However, in an Ugandan study where 100% 
chloroquine failure rate was reported, the pre-treatment 
and recrudescent parasitaemia were due to pfcrtT76 
clones alone (Dossey et al., 2001). 
The inconsistencies surrounding the relationship 
between pfcrt T76 acquisition and chloroquine resistance 
in vivo have been attributed to the modulatory influence 
of other biological, environmental and genetic factors. 
These include variation in chloroquine uptake, 
distribution and metabolism in humans (Kallwarg and 
Harinasuta, 1992; Tett et al., 1996), mutations in other 
loci with pfcrt gene to confer greater stability and 
increase gene expression (Waller et al., 2001), the co-
existence of N86Y point mutation in pfmdr-1 gene 
located on chromosome 5 of P. falciparum as an 
indispensable requirement for in vivo resistance and 
levels of antimalarial immunity dependent on exposure to 
P. falciparum antigens (Chen et al., 2002) and 
antioxidant status (Metzger et al., 2001). 
Acquired antimalarial immunity through previous 
parasite exposure has been found to induce chloroquine 
clearance of P. chabaudi parasitaemia in mice (Cravo et 
al., 2001). While vitamin A has been observed to 
upregulate CD36 expression, decline TNF- expression 
and promote phagocytic uptake of infected erythrocytes 
in animal models (Serghides and Kain, 2002). In several 
human studies, malaria has been associated with 
hypovitaminosis and vitamin A supplementation has 
been shown to reduce malaria morbidity and mortality in 
some clinical trials (Shankar et al., 1999). 
Nigeria is also one of the countries in which 
micronutrient deficiency is a public health problem 
(Copper et al., 2002). However, there is paucity of 
information regarding the micronutrient profiles of the 
study population thereby weakening the possible 
understanding of the impact of antioxidant status on 
malaria in the study area.  
Nevertheless,   the   fact   that    making    or     altering 




antimalarial prophylactic and therapeutic policies in an  
endemic area in order to achieve effective malaria 
control is based on prior understanding of drug 
resistance profile has further made the present molecular 
surveillance study very important. This molecular method 
detects resistance genotypes within hours as against in 
vitro culture method, which has 2 – 3 days diagnostic 
time and in vivo clinical efficacy approach that requires at 
least 14 days for profiling of parasitological resistance 
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